Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarrays

European Journal of Cancer

Volumn 47, Issue 5, 2011, Pages 792-801

  Giusiano, Sophie ^a,b   Cochet, Claude ^b,c,d   Filhol, Odile ^b,c,d   Duchemin Pelletier, Eve ^b,c,d   Secq, Véronique ^a,b   Bonnier, Pascal ^e   Carcopino, Xavier ^e   Boubli, Léon ^e   Birnbaum, Daniel ^f   Garcia, Stéphane ^a,b   Iovanna, Juan ^b   Charpin, Colette ^a,b  

^a HÔPITAL NORD   (France)

^b INSERM   (France)

^c CEA GRENOBLE   (France)

^d UNIV GRENOBLE ALPES   (France)

^e HÔPITAL DE LA CONCEPTION   (France)

^f AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Breast carcinoma; CK2 kinase assay; Protein kinase CK2 subunit; Quantitative immunohistochemistry; Tissue micro arrays; Western blotting

Indexed keywords

BIOLOGICAL MARKER; CASEIN KINASE II; CAVEOLIN; FIBROBLAST GROWTH FACTOR 1; INITIATION FACTOR 4E; STAT1 PROTEIN; VASCULOTROPIN;

ARTICLE; BREAST CARCINOMA; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME SUBUNIT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; WESTERN BLOTTING;

EID: 79952105989     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.11.028     Document Type: Article

References (32)

1. D.W. Litchfield Protein kinase CK2: structure, regulation and role in cellular decisions of life and death Biochem J 369 2003 1 15 (Pubitemid 36174119)
2. N.A. St-Denis, and D.W. Litchfield Protein kinase CK2 in health and disease: from birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival Cell Mol Life Sci 66 2009 1817 1829
3. O. Filhol, and C. Cochet Protein kinase CK2 in health and disease: cellular functions of protein kinase CK2: a dynamic affair Cell Mol Life Sci 66 2009 1830 1839
4. J.S. Duncan, and D.W. Litchfield Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2 Biochim Biophys Acta 1784 2008 33 47
5. G. Wang, K.A. Ahmad, and K. Ahmed Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells Cancer Res 66 2006 2242 2249
6. J. Pallares, D. Llobet, and M. Santacana CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation Am J Pathol 174 2009 287 296
7. E. Landesman-Bollag, R. Romieu-Mourez, and D.H. Song Protein kinase CK2 in mammary gland tumorigenesis Oncogene 20 2001 3247 3257 (Pubitemid 32553677)
8. R. Romieu-Mourez, E. Landesman-Bollag, and D.C. Seldin Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer Cancer Res 61 2001 3810 3818 (Pubitemid 32694998)
9. C.W. Yde, T. Frogne, and A.E. Lykkesfeldt Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT Cancer Lett 256 2007 229 237 (Pubitemid 47418349)
10. B. Laudet, C. Barette, and V. Dulery Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction Biochem J 408 2007 363 373
11. D. Zhu, J. Hensel, and R. Hilgraf Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth Mol Cell Biochem 333 2010 159 167
12. M. Laramas, D. Pasquier, and O. Filhol Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer Eur J Cancer 43 2007 928 934 (Pubitemid 46366689)
13. C. Charpin, P. Vielh, and F. Duffaud Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators J Natl Cancer Inst 86 1994 1539 1545 (Pubitemid 24330219)
14. S. Garcia, J.P. Dales, and J. Jacquemier C-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays Br J Cancer 96 2007 329 335 (Pubitemid 46160639)
15. N.A. Makretsov, D.G. Huntsman, and T.O. Nielsen Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma Clin Cancer Res 10 2004 6143 6151 (Pubitemid 39287520)
16. S. Garcia, J.P. Dales, and E. Charafe-Jauffret Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype Hum Pathol 38 2007 830 841 (Pubitemid 46726507)
17. C. Charpin, V. Secq, and S. Giusiano A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays Int J Cancer 124 2009 2124 2134
18. D.G. Altman, B. Lausen, W. Sauerbrei, and M. Schumacher Dangers of using "optimal" cutpoints in the evaluation of prognostic factors J Natl Cancer Inst 86 1994 829 835 (Pubitemid 2100935)
19. P. Royston, D.G. Altman, and W. Sauerbrei Dichotomizing continuous predictors in multiple regression: a bad idea Stat Med 25 2006 127 141 (Pubitemid 43136953)
20. E. von Elm, D.G. Altman, and M. Egger The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Lancet 370 2007 1453 1457
21. O. Filhol, J. Baudier, and C. Delphin Casein kinase II and the tumor suppressor protein P53 associate in a molecular complex that is negatively regulated upon P53 phosphorylation J Biol Chem 267 1992 20577 20583
22. M. Ruzzene, and L.A. Pinna Addiction to protein kinase CK2: a common denominator of diverse cancer cells? Biochim Biophys Acta 1804 2010 499 504
23. H. Ji, J. Wang, and H. Nika EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin Mol Cell 36 2009 547 559
24. + channels J Biol Chem 284 2009 9331 9340
25. A. Silva, P.Y. Jotta, and A.B. Silveira Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors Haematologica 95 2010 674 678
26. G. Di Maira, F. Brustolon, L.A. Pinna, and M. Ruzzene Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells Cell Mol Life Sci 66 2009 3363 3373
27. M.E. Olsten, D.A. Canton, C. Zhang, P.A. Walton, and D.W. Litchfield The Pleckstrin homology domain of CK2 interacting protein-1 is required for interactions and recruitment of protein kinase CK2 to the plasma membrane J Biol Chem 279 2004 42114 42127 (Pubitemid 39313661)
28. O.A. Timofeeva, S. Plisov, and A.A. Evseev Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis Oncogene 25 2006 7555 7564 (Pubitemid 44924469)
29. A. Soufi, P. Noy, and M. Buckle CK2 phosphorylation of the PRH/Hex homeodomain functions as a reversible switch for DNA binding Nucleic Acids Res 37 2009 3288 3300
30. G. Kallergi, H. Markomanolaki, and V. Giannoukaraki Hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients Breast Cancer Res 11 2009 R84
31. D. Mottet, S.P. Ruys, C. Demazy, M. Raes, and C. Michiels Role for casein kinase 2 in the regulation of HIF-1 activity Int J Cancer 117 2005 764 774 (Pubitemid 41598827)
32. D.V. Rozanov, A.Y. Savinov, and R. Williams Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer Cancer Res 68 2008 4086 4096